Skip to main navigation
Skip to search
Skip to main content
Fox Chase Cancer Center Home
Help & FAQ
Link opens in a new tab
Search content at Fox Chase Cancer Center
Home
Profiles
Research Units
Research Resources
Research Outputs
Prizes
Activities
Press/Media
A review of dendritic cell therapy for cancer: Progress and challenges
Gina M. Mantia-Smaldone
, Christina S. Chu
Clinical Residencies and Fellowships
Surgery
Cancer Signaling and Microenvironment (CSM)
University of Pennsylvania
Research output
:
Contribution to journal
›
Article
›
peer-review
37
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'A review of dendritic cell therapy for cancer: Progress and challenges'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Malignant Neoplasm
100%
Dendritic Cell
100%
Dendritic Cell Therapy
100%
Patient
66%
Combination Therapy
66%
Clinical Trial
66%
Development
33%
Prostate Cancer
33%
T Cell
33%
Antigen
33%
Cancer
33%
Nodular Melanoma
33%
Aptitude
33%
Immune Response
33%
Antigen Presenting Cell
33%
Innate Immunity
33%
Phase II Trials
33%
Cancer Vaccine
33%
Phase I Trials
33%
Antigen Specificity
33%
Immunology and Microbiology
Dendritic Cell
100%
Dendritic Cell Vaccine
66%
Development
33%
T Cell
33%
Aptitude
33%
Immune Response
33%
Innate Immune System
33%
Antigen-Presenting Cell
33%
Antigen
33%
Antigen Specificity
33%
Cancer Vaccine
33%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Antigen
100%
Dendritic Cell Vaccine
66%
Prostate Cancer
33%
Melanoma
33%
Cancer Vaccine
33%